Pragma

The Pragma is a blood test tailored for individuals aged 30 and above without any symptoms suggestive of cancer. This test helps detect cancers in multiple organs, including the breast, lung, stomach, colon, liver, pancreas, bladder, ureter, renal pelvis, and kidney for both men and women, as well as the ovary in women and the prostate in men. The test identifies several types of cancer: adenocarcinoma (AD) in organs like the breast, colon, lung, ovary, pancreas, prostate, stomach, and liver; hepatocellular carcinoma (HCC) in the liver; renal cell carcinoma (RCC) in the kidney; and transitional cell carcinoma (TCC) in the bladder, renal pelvis, and ureter. It can also detect epithelial cancers of squamous origin, though the organ of origin may not always be identified. 

It is a convenient, annual screening test that can be taken from the comfort of your home or office.

Who should get tested? 

• Women and men aged 30 years and older, who have never been diagnosed with any cancer.
• Asymptomatic individuals for cancer at present.
• In individuals with no clinical or radiological suspicion of cancer at present.

Disclaimer: The Pragma test is NOT intended for:

• Patients with any cancer at present or in the past (solid organ or hematolymphoid). 
• Patients in remission after completion of treatment. 
• Patients in whom cancer is being monitored but the patient/doctor wants to rule out other solid organ cancers. 
• Patients with benign conditions with intent to rule out cancer.
• Patients with suspicion of cancer- clinically or radiologically. 
• Individuals with blood transfusion in 72 hours prior to blood draw for EasyCheck-360®.
• Individuals with history of Lymphoma, Leukemia, Polycythemia, Plasmacytoma, Multiple myeloma, Essential thrombocythemia. 
• Individuals with a history of organ transplant, bone marrow transplants. 
• Individuals with physiological conditions like pregnancy. 
• Individuals with Immunocompromised status –Immunocompromised conditions like HIV, Immunomodulator therapy, Anti-immune therapy, and Immunostimulant therapy.